跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
fluticasone + formoterol
首页
药物
fluticasone + formoterol
fluticasone + formoterol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
STABLE PRESSURISED AEROSOL SOLUTION COMPOSITION OF GLYCOPYRRONIUM BROMIDE AND FORMOTEROL COMBINATION
EP 3566694 A1
申请人: CHIESI FARM SPA
优先权: 2013
CN
EP
WO
6 件公开
CN 113143894 A
申请人: CHIESI FARM SPA
优先权: 2013
CN
2 件公开
Pharmaceutical composition
US 10179139 B2
申请人: MALHOTRA GEENA
优先权: 2010
CN
US
4 件公开
Combinations of formoterol and fluticasone propionate for asthma
US 2005287079 A1
申请人: CLARKE JEREMY G
优先权: 2000
US
4 件公开
Formulations
US 2012263766 A1
申请人: MUELLER-WALZ RUDI
优先权: 2009
EP
US
2 件公开
Stabilized powder formulations
US 6369115 B1
申请人: DURA PHARMA INC
优先权: 2000
US
Medicaments for treating respiratory disorders comprising formoterol and fluticasone
US 2003026766 A1
申请人: SANDERS MARK
优先权: 2000
US
Combined doses of formoterol and fluticasone
US 2005053553 A1
申请人: NILSSON THOMAS
优先权: 2003
US
Improved medicinal aerosol formulations
EP 4327807 A3
申请人: JAGOTEC AG
优先权: 2009
EP
Dry powder inhalation medicine composition and preparation method thereof
CN 105982880 A
申请人: SICHUAN HAISCO PHARMACEUTICAL CO LTD
优先权: 2015
CN
AN INHALABLE FIXED DOSE POWDER COMPOSITION COMPRISING GLYCOPYRRONIUM, FORMOTEROL AND FLUTICASONE PROPIONATE
WO 2020240350 A1
申请人: GLENMARK PHARMACEUTICAL LTD
优先权: 2019
WO
第 1 / 2 页
上一页
下一页
药物
反馈